Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron supplementation strategy with Roxadustat in hemodialysis patients with renal anemia
ChiCTR2300078732Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of roxadustat in anemia of renal disease (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Roxadustat dose efficiency (Hb concentration to Roxadustat dose ratio). Planned start Dec 2023; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR2300078732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078732.